American International Group, Inc. Molecular Templates, Inc. Transaction History

American International Group, Inc.

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.81 - $3.43 $14,869 - $62,964	-18,357 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.27 - $4.13 $2,935 - $5,340	-1,293 Reduced 6.58%	18,357 $63,000
Q4 2021 Feb 11, 2022	SELL	$3.37 - $6.87 $1,978 - $4,032	-587 Reduced 2.9%	19,650 $77,000
Q3 2021 Nov 12, 2021	SELL	$5.78 - $7.86 $2,780 - $3,780	-481 Reduced 2.32%	20,237 $136,000
Q2 2021 Aug 13, 2021	BUY	$7.82 - $12.44 $41,336 - $65,757	5,286 Added 34.25%	20,718 $162,000

Q1 2021 May 07, 2021	BUY	$9.33 - $14.05 $373 - $562	40 Added 0.26%	15,432 $195,000
Q4 2020 Feb 12, 2021	SELL	$8.48 - $12.23 $3,739 - $5,393	-441 Reduced 2.79%	15,392 $145,000
Q3 2020 Nov 04, 2020	BUY	$9.99 - $14.41 $10,059 - $14,510	1,007 Added 6.79%	15,833 $173,000
Q2 2020 Aug 12, 2020	BUY	$12.28 - $17.63 $34,420 - $49,416	2,803 Added 23.31%	14,826 $204,000
Q1 2020 May 04, 2020	BUY	$11.31 - $18.26 $15,404 - $24,870	1,362 Added 12.78%	12,023 $160,000
Q4 2019 Feb 05, 2020	SELL	$6.44 - $14.21 $579 - $1,278	-90 Reduced 0.84%	10,661 $149,000
Q3 2019 Nov 08, 2019	SELL	$4.6 - $8.46 $340 - $626	-74 Reduced 0.68%	10,751 $71,000
Q2 2019 Aug 13, 2019	BUY	$5.83 - $8.42 $17,810 - $25,723	3,055 Added 39.32%	10,825 $90,000
Q1 2019 May 06, 2019	SELL	$4.02 - $5.81 $1,013 - $1,464	-252 Reduced 3.14%	7,770 $45,000
Q4 2018 Feb 13, 2019	BUY	$3.35 - $5.68 $6,797 - $11,524	2,029 Added 33.86%	8,022 $32,000
Q3 2018 Nov 09, 2018	BUY	$4.07 - $6.25 $439 - $675	108 Added 1.84%	5,993 $32,000
Q2 2018 Aug 08, 2018	BUY	$5.19 - $9.71 $30,543 - $57,143	5,885 New	5,885 $31,000

499K

Ticker MTEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,351,600
Market Cap $64.8M
Description
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developi...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.